LOGIN  |  REGISTER
Viking Therapeutics

908 Devices to Participate in Upcoming Investor Conferences

October 31, 2023 | Last Trade: US$6.57 0.08 -1.20

BOSTON / Oct 31, 2023 / Business Wire / 908 Devices Inc. (Nasdaq: MASS), a pioneer of purpose-built handheld and desktop devices for chemical and biochemical analysis, today announced it will participate in the following investor conferences.

  • 53rd Annual Baird Industrial Conference
    In-person presentation only on Wednesday, November 8th at 10:35 a.m. Pacific Time / 1:35 a.m. Eastern Time
  • Stifel Healthcare Conference 2023
    Fireside chat on Tuesday, November 14th at 5 a.m. Pacific Time / 8 a.m. Eastern Time
  • 25th Annual Stephens Investment Conference
    Fireside chat on Wednesday, November 15 at 6 a.m. Pacific Time / 9 a.m. Eastern Time

Interested parties may access a live and archived webcast of these sessions on the “Investors” section of the company website at: www.908devices.com.

About 908 Devices

908 Devices is revolutionizing chemical and biochemical analysis with its simple handheld and desktop devices, addressing critical-to-life applications. The Company’s devices are used at the point-of-need to interrogate unknown and invisible materials and provide quick, actionable answers to directly address some of the most critical problems in life sciences research, bioprocessing, pharma/biopharma, forensics and adjacent markets. The Company is headquartered in the heart of Boston, where it designs and manufactures innovative products that bring together the power of mass spectrometry, microfluidic sampling and separations, software automation, and machine learning.

Stock Quote

Featured Stock

Cue Biopharma

Cue Biopharma is developing the first-ever class of therapeutics for the treatment of cancer that mimic the natural signals, or “Cues”, of the immune system. This novel class of injectable biologics selectively engages and modulates tumor-specific T cells directly within the patient’s body to transform...

CLICK TO LEARN MORE

Featured Stock

Astria Therapeutics

Astria Therapeutics is a biopharmaceutical company, and our mission is to bring life-changing therapies to patients and families affected by rare and niche allergic and immunological diseases. Our lead program, STAR-0215, is a monoclonal antibody inhibitor of plasma kallikrein in clinical development...

CLICK TO LEARN MORE

End of content

No more pages to load

Next page